Article Text

Download PDFPDF

Highlights from this issue
  1. Keith Barton,
  2. James Chodosh,
  3. Jost Jonas, Editors in Chief

Statistics from

Shah et al (see page 1332)

For cystoid macular edema secondary to a retinal vein occlusion, specialists would be more likely to choose bevacizumab, and would be less likely to choose aflibercept than if they were choosing the drug to treat their own disease.

Rishi et al (see page 1337)

Combination Photodynamic therapy and intravitreal anti-VEGF (Ranibizumab/Bevacizumab) is associated with better outcomes in eyes with myopic CNV as compared to monotherapy with PDT or anti-VEGF.

Prünte et al (see page 1341)

Switching from a pro re nata (PRN) to treat and extend regimen of ranibizumab in patients with nAMD resulted in significant improvements in functional and anatomical measures whilst reducing the frequency of hospital visits.

Shah et al (see page 1346)

Visual acuity measurement with a high-pass filtered letter chart was observed to be more sensitive to functional loss than conventional charts in age-related macular degeneration.

Finger …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles